John O. Schorge, MD, FACS | Authors

Articles

Cytoreductive Surgery for Advanced Ovarian Cancer: Quo Vadis?

September 15, 2011

This article focuses on the recent debate regarding when-or whether-patients with ovarian cancer should undergo aggressive surgical resection.

Endometrial Cancer: Recent Developments in Evaluation and Treatment

December 01, 1999

We commend Chen et al for their comprehensive review of the evaluation and treatment of endometrial cancer. As the authors state, endometrial cancer is the most common gynecologic malignancy in the United States. Fortunately, it is also one of the most curable. The majority of women with endometrial cancer are treated by surgery alone; primary radiation therapy is generally reserved for patients with unacceptable risks of surgical morbidity. In this commentary, we will address several areas of current controversy.